By Regulatory Approvals — FDA Approves Oveporexton for NT1, Grants RMAT Designation to Sasineprocel in PD, Emerging Literature in Spinal Muscular Atrophy NeurologyLive
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 9, 2026.